Here are three points:
1. CEO Peter Crosby will present at the conference held on Jan. 11, 2017.
2. Mainstay Medical is in the process of bringing ReActiv8 to market.
3. ReActiv8 is an implantable neurostimulation system for patients with chronic low back pain.
More articles on devices:
SpineGuard hits FY 2016 revenue of $7.95M — 5 key notes
Implanet receives 21st patent for JAZZ technology: 4 key points
Mazor Robotics receives record-high 62 system orders in FY 2016 — 7 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
